
Valeant (NYSE: VRX) has announced the establishment of a new patient access and pricing committee that will be responsible for …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

